drugset / Trial / NCT00669123

Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis

NCT00669123

Phase 4 Completed 126 enrolled Bioiberica
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpouse of this study is to determine the efficacy and safety of chondroitin sulphate conventional treatment in patients with both knee osteoarthritis and plaque psoriasis.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin sulphate Unknown 800 mg